06-08-2024 |
PM |
|
ANIP |
ANI Pharmaceuticals, Inc. |
1,340 |
0.72 |
0.64 |
1.06 |
ANI Pharmaceuticals beats top-line and bottom-line estimates; raises FY24 outlook [8/6/2024 6:52 AM] |
63.00 |
3.84 (6.49%) |
0.0 |
0.0 (0.00%) |
48.20 - 70.81 |
255,892 |
170,000 |
0 |
|
|
10-05-2024 |
PM |
|
ANIP |
ANI Pharmaceuticals, Inc. |
1,380 |
0.95 |
0.79 |
0.97 |
ANI Pharmaceuticals beats top-line and bottom-line estimates; reaffirms FY24 outlook [5/10/2024 6:59 AM] |
67.76 |
1.88 (2.85%) |
69.50 |
3.62 (5.49%) |
38.91 - 70.81 |
264,698 |
120,000 |
952 |
|
|
29-02-2024 |
PM |
|
ANIP |
ANI Pharmaceuticals, Inc. |
1,220 |
0.78 |
0.58 |
0.59 |
ANI Pharmaceuticals Non-GAAP EPS of $1.00, revenue of $131.7M [2/29/2024 6:55 AM] |
67.71 |
7.43 (12.33%) |
64.00 |
3.72 (6.17%) |
36.54 - 70.50 |
733,852 |
90,000 |
2,628 |
|
|
08-11-2023 |
PM |
|
ANIP |
ANI Pharmaceuticals, Inc. |
1,280 |
1.05 |
0.56 |
0.46 |
ANI Pharmaceuticals Non-GAAP EPS of $1.27 beats by $0.43, revenue of $131.83M beats by $19.91M [11/8/2023 6:51 AM] |
54.28 |
-9.36 (-14.71%) |
60.00 |
-3.64 (-5.72%) |
32.16 - 65.89 |
925,039 |
140,000 |
12,143 |
|
|
09-08-2023 |
PM |
|
ANIP |
ANI Pharmaceuticals, Inc. |
1,080 |
1.06 |
0.45 |
-0.05 |
ANI Pharmaceuticals Non-GAAP EPS of $1.28 beats by $0.61, revenue of $116.5M beats by $16.64M [8/9/2023 6:53 AM] |
61.01 |
5.08 (9.08%) |
61.60 |
5.67 (10.14%) |
30.53 - 63.10 |
320,774 |
80,000 |
827 |
|
|
08-05-2023 |
PM |
6:50 AM ET (May 8) |
ANIP |
ANI Pharmaceuticals, Inc. |
681.56 |
0.97 |
0.13 |
-0.27 |
ANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31M [5/8/2023 6:56 AM] |
42.51 |
3.37 (8.61%) |
49.00 |
9.86 (25.19%) |
22.31 - 52.23 |
383,767 |
40,000 |
6,114 |
|
|
09-03-2023 |
PM |
6:50 AM ET (Mar 9) |
ANIP |
ANI Pharmaceuticals, Inc. |
715.78 |
0.59 |
0.49 |
0.38 |
ANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06M [3/9/2023 6:52 AM] |
43.25 |
0.12 (0.28%) |
0.0 |
0.0 (0.00%) |
22.31 - 45.99 |
170,384 |
70,000 |
0 |
|
|
09-11-2022 |
PM |
6:50 AM ET (Nov 9) |
ANIP |
ANI Pharmaceuticals, Inc. |
666.37 |
0.46 |
0.40 |
0.83 |
ANI Pharmaceuticals reports Q3 earnings miss; reaffirms FY22 guidance [11/9/2022 6:56 AM] |
34.73 |
-3.53 (-9.24%) |
38.26 |
0.0 (0.00%) |
22.31 - 51.69 |
197,521 |
50,000 |
1,712 |
|
|
08-08-2022 |
PM |
6:50 AM ET (Aug 8) |
ANIP |
ANI Pharmaceuticals, Inc. |
547.24 |
-0.05 |
-0.04 |
0.49 |
ANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecast [8/8/2022 11:01 AM] |
34.78 |
0.17 (0.48%) |
36.00 |
1.38 (3.99%) |
22.31 - 60.23 |
95,368 |
60,000 |
300 |
|
|
10-05-2022 |
PM |
6:50 AM ET (May 10) |
ANIP |
ANI Pharmaceuticals, Inc. |
473.60 |
-0.27 |
-0.05 |
0.92 |
ANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55M [5/10/2022 6:55 AM] |
25.05 |
-1.07 (-4.10%) |
25.01 |
-1.11 (-4.25%) |
24.41 - 60.23 |
172,698 |
140,290 |
185 |
|
|
15-03-2022 |
PM |
6:45 AM ET (Mar 15) |
ANIP |
ANI Pharmaceuticals |
530.00 |
0.38 |
0.82 |
0.00 |
ANI Pharmaceuticals GAAP EPS of $0.54 beats by $0.68, revenue of $60.9M beats by $4.6M [3/15/2022 6:54 AM] |
28.48 |
-7.18 (-20.13%) |
34.50 |
-1.16 (-3.25%) |
0.0 - 0.0 |
969,477 |
0 |
4,053 |
|
|
01-11-2021 |
PM |
7:25 AM ET (Nov 1) |
ANIP |
ANI Pharmaceuticals |
494.00 |
0.83 |
0.71 |
0.00 |
ANI Pharmaceuticals EPS beats by $0.31, beats on revenue [11/1/2021 6:48 AM] |
55.90 |
18.52 (49.53%) |
42.74 |
5.36 (14.34%) |
23.55 - 60.23 |
4,116,513 |
60,000 |
73,355 |
|
|
06-08-2021 |
PM |
6:50 AM ET (Aug 6) |
ANIP |
ANI Pharmaceuticals, Inc. |
432.27 |
0.49 |
0.51 |
0.55 |
ANI Pharmaceuticals EPS beats by $0.07, beats on revenue [8/6/2021 7:38 AM] |
32.86 |
-0.48 (-1.44%) |
34.01 |
0.67 (2.01%) |
23.55 - 40.00 |
36,763 |
60,000 |
295 |
|
|
07-05-2021 |
PM |
6:50 AM ET (May 7) |
ANIP |
ANI Pharmaceuticals, Inc. |
426.11 |
0.92 |
0.58 |
0.89 |
ANI Pharmaceuticals EPS beats by $0.33, beats on revenue [5/7/2021 6:51 AM] |
38.60 |
3.60 (10.29%) |
38.60 |
0.0 (0.00%) |
23.55 - 40.62 |
122,456 |
50,000 |
465 |
|
|
09-03-2021 |
PM |
6:50 AM ET (Mar 9) |
ANIP |
ANI Pharmaceuticals, Inc. |
364.57 |
0.65 |
0.85 |
0.93 |
ANI Pharmaceuticals EPS misses by $0.14, beats on revenue [3/9/2021 6:55 AM] |
29.73 |
-0.61 (-2.01%) |
0.0 |
0.0 (0.00%) |
23.55 - 52.22 |
52,865 |
52,579 |
0 |
|
|
05-11-2020 |
PM |
6:50 AM ET (Nov 5) |
ANIP |
ANI Pharmaceuticals, Inc. |
346.18 |
0.81 |
0.78 |
1.07 |
ANI Pharmaceuticals EPS beats by $0.09, beats on revenue [11/5/2020 6:56 AM] |
26.66 |
-1.51 (-5.36%) |
26.66 |
0.0 (0.00%) |
25.00 - 80.16 |
100,838 |
64,129 |
501 |
|
|
06-08-2020 |
PM |
8:30 AM ET (Aug 6) |
ANIP |
ANI Pharmaceuticals, Inc. |
368.08 |
0.55 |
0.86 |
1.28 |
ANI Pharmaceuticals EPS misses by $0.06, beats on revenue [8/6/2020 6:53 AM] |
29.38 |
-1.62 (-5.24%) |
31.00 |
0.0 (0.00%) |
25.23 - 84.16 |
39,490 |
107,280 |
116,263 |
|
|